Statizoid

Bolivia, Plurinational State of vs Suriname: Access to anti-retroviral drugs, female

Bolivia, Plurinational State of
62.0%
in 2024
Suriname
62.0%
in 2024
Bolivia, Plurinational State of rank
99th
Suriname rank
99th

Access to anti-retroviral drugs, female over time

  • Bolivia, Plurinational State of
  • Suriname
0204060200020122024

How they compare

Bolivia, Plurinational State of currently reports 62.0% against 62.0% in Suriname, a difference of 0.0%.

The two have swapped places 2 times across 25 shared years of data; in 2000 it was Suriname ahead.

Bolivia, Plurinational State of ranks 99th and Suriname ranks 99th of 141 countries.

Suriname has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Bolivia, Plurinational State of Suriname Difference Ahead
2000s 2.1% 9.0% 6.9% Suriname
2010s 29.4% 43.9% 14.5% Suriname
2020s 57.6% 58.8% 1.2% Suriname

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, female, Bolivia, Plurinational State of or Suriname?
Bolivia, Plurinational State of, at 62.0% against 62.0% in Suriname as of 2024.
What is the difference in access to anti-retroviral drugs, female between Bolivia, Plurinational State of and Suriname?
0.0%, with Bolivia, Plurinational State of ahead.
How many years of comparable data are there for Bolivia, Plurinational State of and Suriname?
25 years are reported by both, from 2000 to 2024.
How do Bolivia, Plurinational State of and Suriname rank globally for access to anti-retroviral drugs, female?
Bolivia, Plurinational State of ranks 99th and Suriname ranks 99th of 141 countries.
Where does this data come from?
UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Bolivia, Plurinational State of vs Suriname: Access to anti-retroviral drugs, female. Statizoid, drawing on UNAIDS estimates. Retrieved 16 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/bolivia/suriname/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/bolivia/suriname/">Bolivia, Plurinational State of vs Suriname: Access to anti-retroviral drugs, female</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.